741 related articles for article (PubMed ID: 25683763)
1. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
2. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
[TBL] [Abstract][Full Text] [Related]
3. Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Daoudi K; Das B; Tykalova T; Klempir J; Rusz J
NPJ Parkinsons Dis; 2022 Oct; 8(1):142. PubMed ID: 36302780
[TBL] [Abstract][Full Text] [Related]
4. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy.
Rusz J; Tykalová T; Salerno G; Bancone S; Scarpelli J; Pellecchia MT
J Neurol; 2019 Jun; 266(6):1394-1404. PubMed ID: 30859316
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
[TBL] [Abstract][Full Text] [Related]
6. Acoustical analysis of speech in progressive supranuclear palsy.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
[TBL] [Abstract][Full Text] [Related]
7. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Skrabal D; Tykalova T; Klempir J; Ruzicka E; Rusz J
J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
[TBL] [Abstract][Full Text] [Related]
8. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
Kowalska-Taczanowska R; Friedman A; Koziorowski D
Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
11. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
Miller N; Nath U; Noble E; Burn D
Neurodegener Dis Manag; 2017 Jun; 7(3):191-203. PubMed ID: 28632098
[TBL] [Abstract][Full Text] [Related]
12. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
13. [Parkinsonism-associated speech disorders].
Skripkina NA; Arefyeva AP
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10. Vyp. 2):61-66. PubMed ID: 33205932
[TBL] [Abstract][Full Text] [Related]
14. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
Malkiewicz JJ; Siuda J
Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
[TBL] [Abstract][Full Text] [Related]
15. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Kim KJ; Jeong SJ; Kim JM
Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
18. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
19. [Multiple system atrophy speech assessment: study of five cases].
Knopp DB; Barsottini OG; Ferraz HB
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):619-23. PubMed ID: 12244402
[TBL] [Abstract][Full Text] [Related]
20. Functional mapping in PD and PSP for sustained phonation and phoneme tasks.
Sachin S; Senthil Kumaran S; Singh S; Goyal V; Shukla G; Mahajan H; Behari M
J Neurol Sci; 2008 Oct; 273(1-2):51-6. PubMed ID: 18675995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
